{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:02:10Z","timestamp":1793725330924,"version":"4.6.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T00:00:00Z","timestamp":1416182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111796","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T18:54:48Z","timestamp":1416250488000},"page":"e111796","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of the Quality of Guidelines for Myasthenia Gravis with the AGREE II Instrument"],"prefix":"10.1371","volume":"9","author":[{"given":"Zhenchang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,17]]},"reference":[{"key":"ref1","unstructured":"Myasthenia Gravis Foundation of America. (2013) What is myasthenia gravis (MG)? Retrieved from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.myasthenia.org\/WhatisMG.aspx\" xlink:type=\"simple\">http:\/\/www.myasthenia.org\/WhatisMG.aspx<\/ext-link>"},{"key":"ref2","first-page":"203","article-title":"Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001","volume":"77 (2)","author":"JF Owe","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37 (2)","author":"D Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61 (12)","author":"DP Richman","year":"2003","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005176-200005000-00011","article-title":"Management of acute gastroenteritis in Europe and the impact of new recommendations: a multi-center study","volume":"30 (5)","author":"H Szajewska","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.90.1.1","article-title":"Treatment of infants with acute diarrhoea: what&apos;s recommended and what&apos;s practiced","volume":"90","author":"JA Bezerra","year":"1992","journal-title":"Pediatrics (1pt1)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1542\/peds.93.5.708","article-title":"Barriers to the use of oral rehydration therapy","volume":"93 (5)","author":"EC Reis","year":"1994","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Hoekstra JH (2001) Acute gastroenteritis in industrialized countries: compliance with guidelines for treatment. J Pediatr Gastroenterol Nutr (Suppl 2): S31\u201335.","DOI":"10.1097\/00005176-200110002-00006"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Field MJ, Lohr KN (Eds) (1990) Clinical Practice Guidelines: Directions for a New Program, Institute of Medicine, Washington, DC: National Academy Press.","DOI":"10.17226\/1626"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0b013e3181e233ac","article-title":"Evaluation of the Quality of Guidelines for Acute Gastroenteritis in Children With the AGREE Instrument","volume":"52 (2)","author":"A Lo Vecchio","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Grol R, Cluzeau FA, Burgers JS (2003) Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer (Suppl. 1): S4\u20138.","DOI":"10.1038\/sj.bjc.6601077"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting, and evaluation in healthcare","volume":"182 (18)","author":"MC Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e53566","DOI":"10.1371\/journal.pone.0053566","article-title":"Analysis of Quality of Clinical Practice Guidelines for Otorhinolaryngology in China","volume":"8 (1)","author":"ZW Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jclinepi.2010.12.005","article-title":"Quality varies across clinical practice guidelines for mammography screening in women aged 40\u201349 years as assessed by AGREE and AMSTAR instruments","volume":"64 (9)","author":"BU Burda","year":"2011","journal-title":"J Clinical Epidemiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.2004.06.157","article-title":"International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument","volume":"22 (10)","author":"JS Burgers","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref16","first-page":"3660","article-title":"Quality assessment of clinical guidelines in China: 1993\u20132010","volume":"125 (20)","author":"YL Chen","year":"2012","journal-title":"Chinese Medical Journal"},{"key":"ref17","first-page":"160","article-title":"A brief introduction to Appraisal of Guidelines for Research and Evaluation II J. Journal of Chinese Integrative Medicine","volume":"10 (2)","author":"LM Xie","year":"2012"},{"key":"ref18","first-page":"1479","article-title":"Intravenous innunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases: Present Status and Practical Therapeutic Guidelines","volume":"22 (11)","author":"CD Marinos","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mus.21433","article-title":"Consensus statements: The Use of Intravenous innunoglobulin in the Treatment of Neuromuscular Conditions Report of the AANEM AD HOC Committee","volume":"40 (5)","author":"PD Donofrio","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref20","volume":"45 (6)","unstructured":"Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, et al.. (2012) Recommendations for Myasthenia Gravis Clinical Trials. Muscle Nerve <volume>45 (6)<\/volume>: , 909\u2013917"},{"key":"ref21","first-page":"915","article-title":"AAGBI guidelines on the use of neuromuscular blockade monitoring","volume":"64 (8)","author":"O Adekanye","year":"2009","journal-title":"Anaesthesia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1212\/01.wnl.0000263481.14289.90","article-title":"Evidence report: The medical treatment of ocular myasthenia (an evidence-based review)","volume":"68 (24)","author":"M Benatar","year":"2007","journal-title":"Neurology"},{"key":"ref23","first-page":"368","article-title":"Diagnosis and treatment of myasthenia gravis expert consensus in China","volume":"5 (18)","year":"2011","journal-title":"Chin J Neuroimmunology Neurol"},{"key":"ref24","first-page":"401","article-title":"Diagnosis and treatment of myasthenia gravis, a China expert consensus","volume":"6 (19)","author":"China Immunology nerve immunology branch in","year":"2012","journal-title":"Chin J Neuroimmunology Neurol,2012,"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55 (1)","author":"GS Gronseth","year":"2000","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases","volume":"15 (9)","author":"I Elovaara","year":"2008","journal-title":"Eur J Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17 (7)","author":"GO Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76 (3)","author":"I Cortese","year":"2011","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e31824de293","article-title":"Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"78 (13)","author":"HS Patwa","year":"2012","journal-title":"Neurology"},{"key":"ref30","first-page":"1236","article-title":"Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement","volume":"24 (9)","year":"2001","journal-title":"Muscle Nerve"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.tmrv.2007.01.002","article-title":"Guidelines on the use of intravenous immune globulin for neurologic conditions","volume":"21 (2","author":"T Feasby","year":"2007","journal-title":"Transfus Med Rev"},{"key":"ref32","first-page":"691","article-title":"Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases","volume":"13 (7)","author":"GO Skeie","year":"2006","journal-title":"Eur J Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1468-1331.2000.00158.x","article-title":"EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological Societies","volume":"7 (6)","author":"HJ Willison","year":"2000","journal-title":"Eur J Neurol"},{"key":"ref34","first-page":"673","article-title":"Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases","volume":"51 (4)","author":"V Basci\u0107-Kes","year":"2012","journal-title":"Acta Clin Croat"},{"key":"ref35","first-page":"e58","article-title":"The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies","volume":"19 (6)","author":"P Alonso-Coello","year":"2010","journal-title":"Qual Saf Health Care"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healthpol.2012.06.004","article-title":"Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe","volume":"107 (2\u20133)","author":"C Knai","year":"2012","journal-title":"Health Policy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1741-7015-11-191","article-title":"Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer","volume":"11","author":"TW Huang","year":"2013","journal-title":"BMC Medicine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1741-7015-10-143","article-title":"Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument","volume":"10","author":"B Simone","year":"2012","journal-title":"BMC Medicine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T18:32:27Z","timestamp":1650652347000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111796"}},"subtitle":[],"editor":[{"given":"Hong-Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,17]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111796","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,17]]}}}